PF-04418948

DB12024InvestigationalSmall molecule

Pf 04418948 is under investigation in clinical trial NCT01002963 (A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers).

Formula / weight: C₂₃H₂₀FNO₅ · 409.413 g/mol (avg)
Code names: PF-04418948

Resolves to

Compound

UNIII7Z38E70VFCAS1078166-57-0ChEMBLCHEMBL3286797PubChem25114442

Structure

InChIKeyLWJGMYMNSNVCEM-UHFFFAOYSA-NSMILESCOC1=CC=C2C=C(OCC3(CN(C3)C(=O)C3=CC=C(F)C=C3)C(O)=O)C=CC2=C1

Targets

P43116PTGER2

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with PF-04418948, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account